Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patient
about
sameAs
Assessing the benefit-harm balance at the bedside.Interpretation of drug risk and benefit: individual and population perspectives.American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.Targeted versus global approaches to the management of hypercholesterolaemia.Use of antiplatelet drugs in stroke prevention: time for a rethink?
P2860
Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patient
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aspirin for the prevention of ...... harm in the individual patient
@ast
Aspirin for the prevention of ...... harm in the individual patient
@en
Aspirin for the prevention of ...... harm in the individual patient
@nl
type
label
Aspirin for the prevention of ...... harm in the individual patient
@ast
Aspirin for the prevention of ...... harm in the individual patient
@en
Aspirin for the prevention of ...... harm in the individual patient
@nl
prefLabel
Aspirin for the prevention of ...... harm in the individual patient
@ast
Aspirin for the prevention of ...... harm in the individual patient
@en
Aspirin for the prevention of ...... harm in the individual patient
@nl
P2860
P1476
Aspirin for the prevention of ...... harm in the individual patient
@en
P2093
Alastair Bell
Yoon Kong Loke
P2860
P356
10.1046/J.1365-2125.2003.01774.X
P407
P50
P577
2003-03-01T00:00:00Z